Immune Globulin Intravenous (Human) GC5107

intravenous immunoglobulin · GC Biopharma Corp

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Immune Globulin Intravenous (Human) GC5107, covering 2025-07-25 to 2025-07-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency [Phase 3]

See pricing